ADGRD1 promotes bladder cancer progression and angiogenesis via the PI3K/AKT/mTOR-mediated pro-angiogenic secretome - Top-Institutions - MDSpire

ADGRD1 promotes bladder cancer progression and angiogenesis via the PI3K/AKT/mTOR-mediated pro-angiogenic secretome

  • By

  • Chen Li

  • Zhichao Yang

  • Jialei Zhang

  • Xiaodong Yan

  • Hongwei Su

  • May 28, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of California, Los Angeles (UCLA) Health
    University of California, Los Angeles (UCLA) Health

    Los Angeles, California

    Key Differentiators

    • Oncology

  • #2

    Roswell Park Comprehensive Cancer Center
    Roswell Park Comprehensive Cancer Center

    Buffalo, New York

    Key Differentiators

    • Oncology

  • #3

    University of Rochester
    University of Rochester

    Rochester, New York

    Key Differentiators

    • Oncology

  • #4

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #5

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Oncology

Original Source(s)

ADGRD1 promotes bladder cancer progression and angiogenesis via the PI3K/AKT/mTOR-mediated pro-angiogenic secretome

  • by Chen Li, Zhichao Yang, Jialei Zhang, Xiaodong Yan, Hongwei Su

  • May 28, 2026

Related Content

Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremity

Effect of aesthetic nursing interventions on the health-related quality of life of cervical cancer patients after treatment

Severe immune checkpoint inhibitor-induced 3M syndrome: a case report